Sobi Data at ACR 2025 Highlights Advancing Rare Disease Care
Sobi North America is spotlighting 15 presentations at ACR Convergence 2025, featuring new Phase 3 analyses for its investigational...
Sobi North America is spotlighting 15 presentations at ACR Convergence 2025, featuring new Phase 3 analyses for its investigational...
Enzon Pharmaceuticals and Viskase Companies have amended their previously announced all-stock merger, resetting ownership so Viskase holders will own...
Inotiv will hit the investor circuit in November, with management slated for one-on-one meetings at the UBS Global Healthcare...
Nurexone Biologic will take the regulatory stage at the Precision EV Forum 2025 in Cambridge, UK, where its Director...
Rhythm Pharmaceuticals will report third-quarter 2025 results on November 4 and is lining up two investor discussions on November...
Cytomed Therapeutics has submitted a cash bid to acquire selected assets of TC BioPharm, which entered administration on October...
Iovance Biotherapeutics has granted inducement stock options for 62,790 shares to nine new non-executive hires. The options are priced...
XOMA Royalty Corporation has amended its definitive agreement to acquire LAVA Therapeutics, cutting the initial cash consideration to $1.04...
CorMedix posted preliminary third-quarter 2025 results showing more than $100 million in net revenue, at least $85 million from...
OGRD Alliance is expanding its PLPC-DB phospholipoproteomic module and its Oncovix documentation program from Dubai into Asia and the...